Brand Intelligence Graphcompany
Company Overview
About Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
Business Model & Competitive Advantage
Amgen's portfolio spans oncology (Kyprolis, Blincyto, Lumakras), bone health (Prolia, Xgeva), cardiovascular (Repatha), inflammation (Otezla, Enbrel), rare diseases (Tepezza, Uplizna from Horizon), and general medicine (Aimovig for migraines). The company's biosimilars business is a growing revenue stream as it develops lower-cost alternatives to competitor biologics. Repatha (evolocumab), Amgen's PCSK9 inhibitor for cholesterol management, is among the fastest-growing products. Amgen faces patent cliffs on key products but has a robust pipeline with 30+ molecules in clinical development.
Competitive Landscape 2025–2026
Amgen is one of the most active adopters of AI in drug discovery. The company has built internal machine learning capabilities for protein structure prediction, molecule generation, and clinical trial optimization, with external partnerships supplementing internal R&D. Amgen trades on NASDAQ (AMGN) and is a component of the Dow Jones Industrial Average with a market cap of approximately $130B.
Recent Activity
View all →Key Differentiators
Market Leader
Amgen is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.
Enterprise Scale
With $33.4B in revenue, Amgen operates at enterprise scale with proven market validation.
Top 3 Ranked
Ranked #2 in the Healthcare Tech category, consistently recognized for excellence.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Compare Amgen with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Amgen? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Amgen Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Amgen vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →